PTIX Protagenic Therapeutics
- 1.5687
- -0.0693-4.23%
Protagenic Therapeutics News
10-K/A: Annual report (Amendment)
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WRIGHT TIMOTHY R
Protagenic Therapeutics | 10-K: Annual report
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Stein Robert Benjamin
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Barrage Khalil
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Buell Jennifer
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer ARMEN GARO H
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Corvese Brian
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Arrow Alexander K.
Protagenic Therapeutics | 8-K: Current report
Protagenic Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(5.13%),Steven Boyd(5.13%)
Protagenic Therapeutics | 8-K: Current report
Protagenic Therapeutics | 8-K: Current report
Protagenic Therapeutics: Q3 2023 Earnings Report
Protagenic Therapeutics | DEF 14A: Definitive information statements
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Arrow Alexander K.
Protagenic Therapeutics | 10-Q: Q2 2023 Earnings Report
Protagenic Therapeutics | 10-Q: Q1 2023 Earnings Report
Protagenic Therapeutics | 10-K/A: Annual report (Amendment)
Protagenic Therapeutics: FY2022 Annual Report
10-K | Protagenic Therapeutics, Inc.\new (0001022899) (Filer)
Analysis
Price Target
No Data
